Patent Assignment
Reel/Frame 037102/0573
Assignment of Assignor's Interest
Recorded: 2015-11-12
Pages: 23
Assignor
TRIPEX PHARMACEUTICALS, LLC
Executed: 2015-10-01
Assignee
RAPTOR PHARMACEUTICALS INC
7 HAMILTON LANDING, SUITE 100, NOVATO, CALIFORNIA, 94949
Covered Properties
(24)
Aerosolized Fluoroquinolones and Uses Thereof
Topical Use of Levofloxacin for Reducing Lung Inflammation
Aerosol Fluoroquinolone Formulations for Improved Pharmacokinetics
Aerosolized Fluoroquinolones and Uses Thereof
Aerosolized Fluoroquinolones and Uses Thereof
Aerosolized Fluoroquinolones and Uses Thereof
Aerosolized Fluoroquinolones and Uses Thereof
Methods of Treating a Pulmonary Bacterial Infection Using Fluoroquinolones
Application:
13/278,706 →
Publication:
US 2012/0035166
Use of Aerosolized Antibiotics for Treating Chronic Obstructive Pulmonary Disease
Application:
13/398,310 →
Publication:
US 2012/0237564
Riboflavin Based Aerosol and Use as Placebo in Trials
Application:
13/398,507 →
Publication:
US 2012/0213707
Use of Aerosolized Levofloxacin for Treating Cystic Fibrosis
Aerosolized Fluoroquinolones and Uses Thereof
Application:
14/012,307 →
Publication:
US 2014/0066441
Topical Use of Levofloxacin for Reducing Lung Inflammation
Application:
14/134,348 →
Publication:
US 2014/0105985
Aerosol Fluoroquinolone Formulations for Improved Pharmacokinetics
Aerosolized fluoroquinolones and uses thereof
Application:
60/682,530 →
Aerosolized fluoroquinolones and uses thereof
Application:
60/696,160 →
Topical Use of Levofloxacin for Reducing Lung Inflammation
Application:
61/103,496 →
Aerosol Fluoroquinolone Formulations for Improved Pharmacokinetics
Application:
61/103,501 →
Methods of Treating a Pulmonary Bacterial Infection Using Fluoroquinolones
Application:
61/172,625 →
Use of Aerosolized Levofloxacin for Chronic Obstructive Pulmonary Disease
Application:
61/235,319 →
Use of Aerosolized Levofloxacin for Treating Cystic Fibrosis
Application:
61/240,092 →
Use of Aerosolized Levofloxacin for Chronic Obstructive Pulmonary Disease
Application:
61/240,749 →
Use of Aerosolized Levofloxacin for Treating Chronic Obstructive Pulmonary Disease
Application:
61/249,228 →
Use of Aerosolized Levofloxacin for Treating Cystic Fibrosis
Application:
61/249,231 →
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 10, 2006
From: SURBER, MARK W.; BOSTIAN, KEITH A.; DUDLEY, MICHAEL N.; LOMOVSKAYA, OLGA
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 018097/0385 →
Assignment of Assignor's Interest
Dec 16, 2009
From: GRIFFITH, DAVID C.; DUDLEY, MICHAEL N.; SURBER, MARK W.; BOSTIAN, KEITH A.
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 023664/0233 →
Assignment of Assignor's Interest
Dec 16, 2009
From: DUDLEY, MICHAEL N.; TSIVKOVSKI, RUSLAN Y.; GRIFFITH, DAVID C.; RODNY, OLGA
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 023664/0215 →
Assignment of Assignor's Interest
Apr 5, 2010
From: SURBER, MARK W.; BOSTIAN, KEITH A.; DUDLEY, MICHAEL N.; RODNY, OLGA
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 024189/0906 →
Assignment of Assignor's Interest
Apr 5, 2010
From: SURBER, MARK W.; BOSTIAN, KEITH A.; DUDLEY, MICHAEL N.; RODNY, OLGA
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 024189/0897 →
Assignment of Assignor's Interest
Oct 7, 2010
From: LOUTIT, JEFFERY S.; MORGAN, ELIZABETH E.; GRIFFITH, DAVID C.; DUDLEY, MICHAEL N.
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 025110/0047 →
Assignment of Assignor's Interest
Oct 7, 2010
From: DUDLEY, MICHAEL N.; BERKLEY, NEIL; GRIFFITH, DAVID C.; LOUTIT, JEFFERY S.
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 025110/0021 →
Assignment of Assignor's Interest
Oct 7, 2010
From: LOUTIT, JEFFERY S.; MORGAN, ELIZABETH E.; DUDLEY, MICHAEL N.; GRIFFITH, DAVID C.
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 025109/0871 →
Assignment of Assignor's Interest
Apr 16, 2012
From: SURBER, MARK W.; BOSTIAN, KEITH A.; DUDLEY, MICHAEL N.; LOMOVSKAYA, OLGA
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 028052/0773 →
Assignment of Assignor's Interest
Jun 1, 2012
From: DUDLEY, MICHAEL N.; BERKLEY, NEIL; GRIFFITH, DAVID C.; LOUTIT, JEFFERY S.
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 028304/0930 →
Assignment of Assignor's Interest
Jul 5, 2012
From: GRIFFITH, DAVID C.
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 028492/0033 →
Assignment of Assignor's Interest
Jul 20, 2012
From: LOUTIT, JEFFERY S.; MORGAN, ELIZABETH E.; DUDLEY, MICHAEL N.; GRIFFITH, DAVID C.
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 028597/0123 →
Assignment of Assignor's Interest
Oct 26, 2012
From: DUDLEY, MICHAEL N.; GRIFFITH, DAVID C.; RODNY, OLGA
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 029199/0277 →
Assignment of Assignor's Interest
Apr 24, 2014
From: DUDLEY, MICHAEL N; TSIVKOVSKI, RUSLAN Y; GRIFFITH, DAVID C; RODNY, OLGA
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 032752/0265 →
Assignment of Assignor's Interest
Jul 31, 2015
From: SURBER, MARK W.; BOSTIAN, KEITH A.; DUDLEY, MICHAEL N.; LOMOVSKAYA, OLGA
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 036227/0723 →
Assignment of Assignor's Interest
Jul 31, 2015
From: GRIFFITH, DAVID C.; DUDLEY, MICHAEL N.; SURBER, MARK W.; BOSTIAN, KEITH A.
To: MPEX PHARMACEUTICALS, INC.
Reel/Frame 036227/0778 →
Assignment of Assignor's Interest
Oct 28, 2015
From: MPEX PHARMACEUTICAL, INC.
To: TRIPEX PHARMACEUTICALS, LLC
Reel/Frame 036906/0924 →
Security Agreement
Oct 26, 2016
From: RAPTOR PHARMACEUTICALS INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 040479/0578 →
Change of Name
Dec 2, 2016
From: RAPTOR PHARMACEUTICALS INC.
To: HORIZON ORPHAN LLC.
Reel/Frame 040827/0163 →
Release of Security Interest
Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS U.S. HOLDING LLC (FKA RAPTOR PHARMACEUTICALS INC.)
Reel/Frame 065178/0955 →
Merger and Change of Name
Dec 21, 2023
From: HORIZON THERAPEUTICS, LLC; HORIZON ORPHAN LLC
To: HORIZON THERAPEUTICS U.S. HOLDING LLC
Reel/Frame 065928/0608 →